Source: Annual Congress 2002 - Biology of immune recognition
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
K. Matsunaga, M. Nakanishi, T. Yamagata, Y. Minakata, M. Mune, S. Yukawa (Wakayama, Japan). In vitro immunomodulatory effects of epigallocatechin gallate on mycobacterium avium infection of alveolar macrophages. Eur Respir J 2002; 20: Suppl. 38, 1416

Member's Comments

No comment yet.

Related content which might interest you: In-vitro effect of bioactive fractions of Cinnamomum verum(Cv) on cytokine levels in Mycobacterium tuberculosis (MTB) infected Macrophages. Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 In vitro susceptibility of M. avium against protionamide Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections Source: Eur Respir J, 49 (5) 1700083; 10.1183/13993003.00083-2017 Year: 2017 Mycobacterium tuberculosis blocks phagolysosome maturation in alveolar macrophages of tuberculosis patients Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Efficiency of bactericidal activity of liposomal mycobacteriophages against intracellular Mycobacteria tuberculosis in the model of macrophages RAW 264 Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019 Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016 Year: 2017 Apoptosis plays a protective role against Mycobacterium avium infection in mice Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017 IL-4 subverts mycobacterial containment in Mycobacterium tuberculosis-infected human macrophages Source: Eur Respir J, 54 (2) 1802242; 10.1183/13993003.02242-2018 Year: 2019 Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa Source: Eur Respir J 2001; 18: Suppl. 33, 480s Year: 2001 Mycobacterium tuberculosis modulates mitochondrial function in human macrophages Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020 Mycobacterium tuberculosis modulates mitochondrial function in human macrophages Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 In vitro susceptibility testing of bedaquiline against mycobacteria avium-intracellulare complex Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections Year: 2020 In vitro susceptibility of mycobacterium bovis against moxifloxacin Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Mycobacterium tuberculosis reside only inside phagosomes in alveolar macrophages of tuberculosis patients Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Pulmonary infection with Mycobacterium avium in immunocompetent children without IFN-γ (interferon-gamma) or IL-12-receptor deficiency Source: Eur Respir J 2001; 18: Suppl. 33, 511s Year: 2001 Pulmonary Mycobacterium avium complex infection: association with NRAMP1 polymorphisms Source: Eur Respir J 2007; 30: 90-96 Year: 2007 Mycobacterium avium complex infection: phenotypes and outcomes Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017 Year: 2017 Invasive Mycobacterium avium intracellulare infection Source: Eur Respir J 2006; 28: Suppl. 50, 312s Year: 2006 Assessment of differential activity of reactive radicals in cell lines infected with Mycobacterium tuberculosis . Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Infection of the respiratory mucosa by Mycobacterium avium complex (MAC), Mycobacterium tuberculosis (MTB) and Mycobacterium smegmatis (MS) Source: Eur Respir J 2001; 18: Suppl. 33, 308s Year: 2001